These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 24898950)
21. Early lessons learned from extramural school programs that offer HPV vaccine. Hayes KA; Entzel P; Berger W; Caskey RN; Shlay JC; Stubbs BW; Smith JS; Brewer NT J Sch Health; 2013 Feb; 83(2):119-26. PubMed ID: 23331272 [TBL] [Abstract][Full Text] [Related]
22. Human papillomavirus (HPV) vaccine coverage achievements in low and middle-income countries 2007-2016. Gallagher KE; Howard N; Kabakama S; Mounier-Jack S; Burchett HED; LaMontagne DS; Watson-Jones D Papillomavirus Res; 2017 Dec; 4():72-78. PubMed ID: 29179873 [TBL] [Abstract][Full Text] [Related]
23. Evidence of effective delivery of the human papillomavirus (HPV) vaccine through a publicly funded, school-based program: the Ontario Grade 8 HPV Vaccine Cohort Study. Lim WT; Sears K; Smith LM; Liu G; Lévesque LE BMC Public Health; 2014 Oct; 14():1029. PubMed ID: 25278003 [TBL] [Abstract][Full Text] [Related]
24. Human Papillomavirus Vaccination Coverage Among School Girls in a Demonstration Project - Botswana, 2013. Raesima MM; Forhan SE; Voetsch AC; Hewitt S; Hariri S; Wang SA; Pelletier AR; Letebele M; Pheto T; Ramogola-Masire D; El-Halabi S MMWR Morb Mortal Wkly Rep; 2015 Oct; 64(40):1147-9. PubMed ID: 26468997 [TBL] [Abstract][Full Text] [Related]
25. Human papillomavirus vaccine introduction--the first five years. Markowitz LE; Tsu V; Deeks SL; Cubie H; Wang SA; Vicari AS; Brotherton JM Vaccine; 2012 Nov; 30 Suppl 5():F139-48. PubMed ID: 23199957 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of an intervention providing HPV vaccine in schools. Stubbs BW; Panozzo CA; Moss JL; Reiter PL; Whitesell DH; Brewer NT Am J Health Behav; 2014 Jan; 38(1):92-102. PubMed ID: 24034684 [TBL] [Abstract][Full Text] [Related]
27. Human Papillomavirus Vaccine Introduction in South Africa: Implementation Lessons From an Evaluation of the National School-Based Vaccination Campaign. Delany-Moretlwe S; Kelley KF; James S; Scorgie F; Subedar H; Dlamini NR; Pillay Y; Naidoo N; Chikandiwa A; Rees H Glob Health Sci Pract; 2018 Oct; 6(3):425-438. PubMed ID: 30143561 [TBL] [Abstract][Full Text] [Related]
28. Literature review of HPV vaccine delivery strategies: considerations for school- and non-school based immunization program. Paul P; Fabio A Vaccine; 2014 Jan; 32(3):320-6. PubMed ID: 24295804 [TBL] [Abstract][Full Text] [Related]
29. High uptake of Gardasil vaccine among 9 - 12-year-old schoolgirls participating in an HPV vaccination demonstration project in KwaZulu-Natal, South Africa. Moodley I; Tathiah N; Mubaiwa V; Denny L S Afr Med J; 2013 May; 103(5):318-21. PubMed ID: 23971122 [TBL] [Abstract][Full Text] [Related]
30. Lessons learned from HPV vaccine delivery in low-resource settings and opportunities for HIV prevention, treatment, and care among adolescents. Tsu VD; Cernuschi T; LaMontagne DS J Acquir Immune Defic Syndr; 2014 Jul; 66 Suppl 2():S209-16. PubMed ID: 24918597 [TBL] [Abstract][Full Text] [Related]
31. Mothers' preferences and willingness to pay for HPV vaccines in Vinh Long Province, Vietnam. Poulos C; Yang JC; Levin C; Van Minh H; Giang KB; Nguyen D Soc Sci Med; 2011 Jul; 73(2):226-34. PubMed ID: 21733609 [TBL] [Abstract][Full Text] [Related]
32. Human papillomavirus vaccine uptake in boys and girls in a school-based vaccine delivery program in Prince Edward Island, Canada. McClure CA; MacSwain MA; Morrison H; Sanford CJ Vaccine; 2015 Apr; 33(15):1786-90. PubMed ID: 25731789 [TBL] [Abstract][Full Text] [Related]
33. Implementation of a Postpartum HPV Vaccination Program in a Southeast Texas Hospital: A Qualitative Study Evaluating Health Care Provider Acceptance. Gross TT; Rahman M; M Wright A; M Hirth J; Sarpong KO; Rupp RE; D Barrett A; Berenson AB Matern Child Health J; 2016 Nov; 20(Suppl 1):154-163. PubMed ID: 27316631 [TBL] [Abstract][Full Text] [Related]
34. Human papillomavirus vaccine delivery strategies that achieved high coverage in low- and middle-income countries. LaMontagne DS; Barge S; Le NT; Mugisha E; Penny ME; Gandhi S; Janmohamed A; Kumakech E; Mosqueira NR; Nguyen NQ; Paul P; Tang Y; Minh TH; Uttekar BP; Jumaan AO Bull World Health Organ; 2011 Nov; 89(11):821-830B. PubMed ID: 22084528 [TBL] [Abstract][Full Text] [Related]
35. Ethical issues related to human papillomavirus vaccination programs: an example from Bangladesh. Salwa M; Abdullah Al-Munim T BMC Med Ethics; 2018 Jun; 19(Suppl 1):39. PubMed ID: 29945621 [TBL] [Abstract][Full Text] [Related]
36. Human papillomavirus vaccine introduction in Vietnam: formative research findings. Nghi NQ; Lamontagne DS; Bingham A; Rafiq M; Mai le TP; Lien NT; Khanh NC; Hong DT; Huyen DT; Tho NT; Hien NT Sex Health; 2010 Sep; 7(3):262-70. PubMed ID: 20719213 [TBL] [Abstract][Full Text] [Related]
37. Promoting adolescent health through integrated human papillomavirus vaccination programs: The experience of Togo. Engel D; Afeli ADJ; Morgan C; Zeck W; Ross DA; Vyankandondera J; Bloem P; Adjeoda KR Vaccine; 2022 Mar; 40 Suppl 1():A100-A106. PubMed ID: 34844819 [TBL] [Abstract][Full Text] [Related]
38. Barriers and facilitators of implementing a collaborative HPV vaccine program in an incarcerated population: A case study. Emerson A; Allison M; Kelly PJ; Ramaswamy M Vaccine; 2020 Mar; 38(11):2566-2571. PubMed ID: 32046888 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of human papilloma virus (HPV) vaccination strategies and vaccination coverage in adolescent girls worldwide. Owsianka B; Gańczak M Przegl Epidemiol; 2015; 69(1):53-8, 151-5. PubMed ID: 25862448 [TBL] [Abstract][Full Text] [Related]
40. Facilitators and barriers of human papillomavirus vaccine uptake in young females 18-26 years old in Singapore: A qualitative study. Lim ASE; Lim RBT Vaccine; 2019 Sep; 37(41):6030-6038. PubMed ID: 31473002 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]